{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:11:57Z","timestamp":1764688317934},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,11,22]],"date-time":"2002-11-22T00:00:00Z","timestamp":1037923200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/1471-2458-2-26","type":"journal-article","created":{"date-parts":[[2003,1,7]],"date-time":"2003-01-07T15:47:36Z","timestamp":1041954456000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil"],"prefix":"10.1186","volume":"2","author":[{"given":"Lia L","family":"Lewis-Ximenez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kycia MR","family":"do \u00d3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleber F","family":"Ginuino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jucimara C","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann G","family":"Schatzmayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherri","family":"Stuver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara FT","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,11,22]]},"reference":[{"issue":"suppl 3","key":"43_CR1","doi-asserted-by":"publisher","first-page":"S574","DOI":"10.1093\/clinids\/11.Supplement_3.S574","volume":"11","author":"JE Maynard","year":"1989","unstructured":"Maynard JE, Kane MA, Hadler SC: Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis. 1989, 11 (suppl 3): S574-S578.","journal-title":"Rev Infect Dis"},{"key":"43_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1086\/314768","volume":"179","author":"JS Wu","year":"1999","unstructured":"Wu JS, Hwang LY, Goodman KJ, Beasley RP: Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis. 1999, 179: 1319-1325. 10.1086\/314768.","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"43_CR3","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/S0264-410X(99)00459-4","volume":"18","author":"G Da Villa","year":"2000","unstructured":"Da Villa G: Rationale for the infant and adolescent vaccination programmes in Italy. Vaccine. 2000, 18 (suppl 1): S31-S34. 10.1016\/S0264-410X(99)00459-4.","journal-title":"Vaccine"},{"issue":"suppl 1","key":"43_CR4","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S0264-410X(99)00460-0","volume":"18","author":"K Huang","year":"2000","unstructured":"Huang K, Lin S: Nationwide vaccination: A success story in Taiwan. Vaccine. 2000, 18 (suppl 1): S35-S38. 10.1016\/S0264-410X(99)00460-0.","journal-title":"Vaccine"},{"key":"43_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJM198209093071103","volume":"307","author":"AG Mulley","year":"1982","unstructured":"Mulley AG, Silverstein MD, Dienstag JL: Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis,. N Engl J Med. 1982, 307: 644-652.","journal-title":"N Engl J Med"},{"key":"43_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0140-6736(87)90971-8","volume":"2","author":"D Lahaye","year":"1987","unstructured":"Lahaye D, Strauss P, Baleux C, van Ganse W: Cost-benefit analysis of hepatitis-B vaccination,. Lancet. 1987, 2: 441-443. 10.1016\/S0140-6736(87)90971-8.","journal-title":"Lancet"},{"key":"43_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/ije\/27.1.91","volume":"27","author":"T Skov","year":"1998","unstructured":"Skov T, Deddens J, Petersen MR, Endahl L: Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol. 1998, 27: 91-95. 10.1093\/ije\/27.1.91.","journal-title":"Int J Epidemiol"},{"key":"43_CR8","first-page":"343","volume":"364","author":"E Juarez","year":"1991","unstructured":"Juarez E, do Amaral Junior C, Pinheiro F, Biellik R: Hepatitis B and delta vaccination program in the western Amazon region of Brazil. Prog Clin Biol Res. 1991, 364: 343-349.","journal-title":"Prog Clin Biol Res"},{"key":"43_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1590\/S1020-49891999000600018","volume":"6","author":"CMT Martelli","year":"1999","unstructured":"Martelli CMT, Turchi MD, Souto FJ, S\u00e1ez-Alqu\u00e9zar A, Andrade ALSS, Zicker F: Anti-HBc testing for blood donors in areas with intermediate hepatitis B endemicity. Rev Panam Salud Publica. 1999, 6: 69-73.","journal-title":"Rev Panam Salud Publica"},{"key":"43_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1590\/S1020-49891999001100002","volume":"6","author":"TR Silveira","year":"1999","unstructured":"Silveira TR, da Fonseca JC, Rivera L, et al: Hepatitis B seroprevalence in Latin America. Rev Panam Salud Publica. 1999, 6: 378-383.","journal-title":"Rev Panam Salud Publica"},{"key":"43_CR11","unstructured":"Minist\u00e9rio da Sa\u00fade\/Funda\u00e7\u00e3o Nacional da Sa\u00fade\/CENEPI\/Vigil\u00e2ncia Epidemiol\u00f3gica: [http:\/\/www.saude.gov.br\/inform\/idb97\/morbid\/D01\/d01h.htm]"},{"key":"43_CR12","first-page":"279","volume-title":"In: Viral hepatitis","author":"W Szmuness","year":"1978","unstructured":"Szmuness W, Harley EJ, Ikram H, Stevens CE: Sociodemographic aspects of the epidemiology of hepatitis B. In: Viral hepatitis. Edited by: Vyas GN, Cohen SN, Schmid R. 1978, Philadelphia: Franklin Institute Press, 279-320."},{"key":"43_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7326\/0003-4819-83-4-489","volume":"83","author":"W Szmuness","year":"1975","unstructured":"Szmuness W, Much I, Prince AM, et al: On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med. 1975, 83: 489-495.","journal-title":"Ann Intern Med"},{"key":"43_CR14","first-page":"692","volume":"78","author":"E Nordenfelt","year":"1970","unstructured":"Nordenfelt E, Lindholm T, Dahlquist E: A hepatitis epidemic in a dialysis unit. Occurrence and persistence of Australia-antigen among patients and staff. Acta Pathol Microbiol Scand [B] Microbiol Immunol. 1970, 78: 692-700.","journal-title":"Acta Pathol Microbiol Scand [B] Microbiol Immunol"},{"key":"43_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1136\/bmj.3.5723.603","volume":"3","author":"AH Knight","year":"1970","unstructured":"Knight AH, Fox RA, Baillod RA, Niazi SP, Sherlock S, Moorhead JF: Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J. 1970, 3: 603-606.","journal-title":"Br Med J"},{"key":"43_CR16","first-page":"294, 296, 298","volume":"10","author":"SS Seow","year":"1981","unstructured":"Seow SS: Hepatitis in drug dependents. Aust Fam Physician. 1981, 10: 294, 296, 298-","journal-title":"Aust Fam Physician"},{"key":"43_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/infdis\/129.2.210","volume":"129","author":"MS Favero","year":"1974","unstructured":"Favero MS, Bond WW, Petersen NJ, Berquist KR, Maynard JE: Detection methods for study of the stability of hepatitis B antigen on surfaces. J Infect Dis. 1974, 129: 210-212.","journal-title":"J Infect Dis"},{"key":"43_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000045880","volume":"87","author":"LL Lewis-Ximenez","year":"2001","unstructured":"Lewis-Ximenez LL, Oliveira JM, Mercadante LAC, et al: Serological and Vaccination Profile of Hemodialysis Patients during an Outbreak of Hepatitis B Virus Infection. Nephron. 2001, 87: 19-26. 10.1159\/000045880.","journal-title":"Nephron"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-2-26\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-2-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:37:13Z","timestamp":1726245433000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-2-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,22]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-2-26","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2002,11,22]]},"assertion":[{"value":"21 March 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"26"}}